Literature DB >> 23963364

Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition.

Diewertje I Bink1, Katja Ritz, Eleonora Aronica, Louise van der Weerd, Mat J A P Daemen.   

Abstract

Recent clinical data indicates that hemodynamic changes caused by cardiovascular diseases such as atherosclerosis, heart failure, and hypertension affect cognition. Yet, the underlying mechanisms of the resulting vascular cognitive impairment (VCI) are poorly understood. One reason for the lack of mechanistic insights in VCI is that research in dementia primarily focused on Alzheimer's disease models. To fill in this gap, we critically reviewed the published data and various models of VCI. Typical findings in VCI include reduced cerebral perfusion, blood-brain barrier alterations, white matter lesions, and cognitive deficits, which have also been reported in different cardiovascular mouse models. However, the tests performed are incomplete and differ between models, hampering a direct comparison between models and studies. Nevertheless, from the currently available data we conclude that a few existing surgical animal models show the key features of vascular cognitive decline, with the bilateral common carotid artery stenosis hypoperfusion mouse model as the most promising model. The transverse aortic constriction and myocardial infarction models may be good alternatives, but these models are as yet less characterized regarding the possible cerebral changes. Mixed models could be used to study the combined effects of different cardiovascular diseases on the deterioration of cognition during aging.

Entities:  

Mesh:

Year:  2013        PMID: 23963364      PMCID: PMC3824184          DOI: 10.1038/jcbfm.2013.140

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  148 in total

1.  Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging.

Authors:  Daniel Bos; Meike W Vernooij; Suzette E Elias-Smale; Benjamin F J Verhaaren; Henri A Vrooman; Albert Hofman; Wiro J Niessen; Jacqueline C M Witteman; Aad van der Lugt; M Arfan Ikram
Journal:  Alzheimers Dement       Date:  2012-04-25       Impact factor: 21.566

Review 2.  Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline.

Authors:  Kazuo Kitagawa
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.

Authors:  John D Fryer; Ronald B Demattos; Lynn M McCormick; Mark A O'Dell; Michael L Spinner; Kelly R Bales; Steven M Paul; Patrick M Sullivan; Maia Parsadanian; Guojun Bu; David M Holtzman
Journal:  J Biol Chem       Date:  2005-05-11       Impact factor: 5.157

4.  Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema.

Authors:  John R Lynch; Jose A Pineda; Duncan Morgan; Lin Zhang; David S Warner; Helen Benveniste; Daniel T Laskowitz
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

5.  Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents.

Authors:  Kayoko Nakaji; Masafumi Ihara; Chiaki Takahashi; Shigeyoshi Itohara; Makoto Noda; Ryosuke Takahashi; Hidekazu Tomimoto
Journal:  Stroke       Date:  2006-09-28       Impact factor: 7.914

6.  Exercise protects against high-fat diet-induced hypothalamic inflammation.

Authors:  Chun-Xia Yi; Omar Al-Massadi; Elizabeth Donelan; Maarit Lehti; Jon Weber; Chandler Ress; Chitrang Trivedi; Timo D Müller; Stephen C Woods; Susanna M Hofmann
Journal:  Physiol Behav       Date:  2012-03-29

7.  White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion.

Authors:  Masunari Shibata; Ryo Ohtani; Masafumi Ihara; Hidekazu Tomimoto
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

Review 8.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

9.  Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion.

Authors:  Michell M Reimer; Jamie McQueen; Luke Searcy; Gillian Scullion; Barbara Zonta; Anne Desmazieres; Philip R Holland; Jessica Smith; Catherine Gliddon; Emma R Wood; Pawel Herzyk; Peter J Brophy; James McCulloch; Karen Horsburgh
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

10.  Increase of arginase activity in old apolipoprotein-E deficient mice under Western diet associated with changes in neurovascular unit.

Authors:  Jérôme Badaut; Jean-Christophe Copin; Andrew M Fukuda; Yvan Gasche; Karl Schaller; Rafaela F da Silva
Journal:  J Neuroinflammation       Date:  2012-06-18       Impact factor: 8.322

View more
  40 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Neurobehavioral and imaging correlates of hippocampal atrophy in a mouse model of vascular cognitive impairment.

Authors:  Kristen L Zuloaga; Wenri Zhang; Lauren A Yeiser; Blair Stewart; Ayaka Kukino; Xiao Nie; Natalie E Roese; Marjorie R Grafe; Martin M Pike; Jacob Raber; Nabil J Alkayed
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

3.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 4.  Animal Models of Vascular Cognitive Impairment and Dementia (VCID).

Authors:  Jennifer Gooch; Donna M Wilcock
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

Review 5.  White matter hyperintensities, cognitive impairment and dementia: an update.

Authors:  Niels D Prins; Philip Scheltens
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

6.  Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice.

Authors:  I A C Arnoldussen; M Wiesmann; C E Pelgrim; E M Wielemaker; W van Duyvenvoorde; P L Amaral-Santos; L Verschuren; B J F Keijser; A Heerschap; R Kleemann; P Y Wielinga; A J Kiliaan
Journal:  Int J Obes (Lond)       Date:  2017-02-21       Impact factor: 5.095

Review 7.  Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Authors:  Rebecca Parodi-Rullán; Je Yeong Sone; Silvia Fossati
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 8.  Vascular cognitive impairment and dementia.

Authors:  Philip B Gorelick; Scott E Counts; David Nyenhuis
Journal:  Biochim Biophys Acta       Date:  2015-12-15

Review 9.  The pericyte: a forgotten cell type with important implications for Alzheimer's disease?

Authors:  Ethan A Winkler; Abhay P Sagare; Berislav V Zlokovic
Journal:  Brain Pathol       Date:  2014-07       Impact factor: 6.508

10.  A mouse model of subcortical vascular dementia reflecting degeneration of cerebral white matter and microcirculation.

Authors:  Eek-Sung Lee; Jin-Hui Yoon; Jiye Choi; Faris R Andika; Taekwan Lee; Yong Jeong
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.